Pascal Minne is Director & 10% Owner at LEXICON PHARMACEUTICALS, INC./DE (LXRX). They have made 5 open-market trades across 3 companies since 2014, most recently 2020-12-08.
CIK 0001460839
5 open-market purchases totalling $177.2M since 2014, never a sale. Across 5 scored buys the stock is down 14.6% at ninety days, and 18.7 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 20% | 40% | 40% |
| Avg Move | -9.8% | -6.0% | -14.6% |
| Alpha | -8.3% | -7.9% | -18.7% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SEER | BUY | 2020-12-08 | 2020-12-10 | $19.00 | $15.0M | -21.4% | -23.4% | -45.8% |
| LXRX | BUY | 2018-06-27 | 2018-06-29 | $12.51 | $4.6M | +2.6% | -5.5% | -10.7% |
| LXRX | BUY | 2018-06-19 | 2018-06-21 | $13.31 | $1.3M | -1.7% | -3.5% | -18.9% |
| LXRX | BUY | 2014-11-26 | 2014-11-26 | $1.01 | $150.7M | -21.0% | +0.6% | +0.6% |
| WTW | BUY | 2014-08-04 | 2014-08-06 | $21.59 | $5.6M | -7.3% | +2.0% | +2.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.